Spots Global Cancer Trial Database for Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
Official Title: An Open, Non-interventional, Retrospective, Comparative, Multicenter Follow-up Study in Patients Included in the Previously Completed Clinical Study PCB305/04, to Assess Longer-term Recurrence Rates in Patients After Hexvix® (Cysview®)Fluorescence Cystoscopy/Transurethral Resection of the Bladder (TURB) or White Light Cystoscopy/TURB
Study ID: NCT01166230
Conditions
Interventions
Study Description
Brief Summary: The study is intended to investigate whether the improved initial detection and resection of bladder cancer lesions in patients with non-muscle invasive bladder cancer with Hexvix (Cysview) fluorescence cystoscopy/TURB will lead to a longer-term reduction in recurrences compared to standard white light cystoscopy/TURB.
Detailed Description: A previously completed pivotal clinical study PC B305/04 demonstrated reduced recurrence rates for patients with papillary bladder cancer who underwent Hexvix (Cysview) and white light cystoscopy and transurethral resection (TURB) of the bladder compared to patients who underwent white light cystoscopy and TURB alone. The present study is intended to investigate whether the improved initial detection and resection of bladder cancer lesions in patients with non-muscle invasive bladder cancer with Hexvix (Cysview) fluorescence cystoscopy/TURB will also lead to a longer-term reduction in recurrences compared to standard white light cystoscopy/TURB. No safety data was collected.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Stanford Cancer Center, Department of Urology, Stanford, California, United States
V.A. Medical Center, Gainesville, Florida, United States
University of Miami School of Medicine, Miami, Florida, United States
South Florida Clinical Research Center, Inc., Pembroke Pines, Florida, United States
The Emory Clinic, Dept of Urology, Atlanta, Georgia, United States
Boston University School of Medicine, Boston, Massachusetts, United States
Urologic Clinical Research Unit, Gonda 7102, Mayo Clinic Rochester, Rochester, Minnesota, United States
Hackensack University Medical Center, Hackensack, New Jersey, United States
Mount Sinai Medical Center, Department of Urology, New York, New York, United States
URMC, Rochester, New York, United States
Thomas Jefferson Medical College, Department of Neurology, Philadelphia, Pennsylvania, United States
Vanderbilt University Medical Center, Department of Urologic Surgery, Nashville, Tennessee, United States
Baylor College of Medicine, Scott Department of Urology, Houston, Texas, United States
The University of Texas MD Anderson cancer center, Houston, Texas, United States
AKH, Klinik für Urologie der Universität Wien, Wien, , Austria
Kingston General Hospital, Kingston, Ontario, Canada
CHUQ Hotel-Dieu de Quebec, Quebec, , Canada
University Clinic of Giessen, Department of Urology, Giessen, , Germany
Klinikum der Universität München-Großhardern, Urologische Klinik und Poliklinik, München, , Germany
Urologische Klinik München-Planegg, Planegg, , Germany
Akadem. Lehrkrankenhaus der Uni Regensburg, Klinik für Urologie, Regensburg, , Germany
Universitätsklinik Tuebingen, Universitätsklinik für Urologie, Tuebingen, , Germany
Department of Urology, Academic Medical Center, University of Amsterdam, Amsterdam, , Netherlands
Department of Urology, UMC St. Radboud, Nijmegen, , Netherlands
Contact Details
Name: Herbert Barton Grossman, MD
Affiliation: The University of Texas MD Anderson Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
